Edmund Dunn - Aug 8, 2023 Form 3 Insider Report for Monte Rosa Therapeutics, Inc. (GLUE)

Role
Principal Accounting Officer
Signature
/s/ Phil Nickson, Attorney-in-Fact
Stock symbol
GLUE
Transactions as of
Aug 8, 2023
Transactions value $
$0
Form type
3
Date filed
8/18/2023, 04:00 PM
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GLUE Common Stock 16.8K Aug 8, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GLUE Stock Option (Right to Buy) Aug 8, 2023 Common Stock 14.5K $6.14 Direct F2
holding GLUE Stock Option (Right to Buy) Aug 8, 2023 Common Stock 25.7K $13.41 Direct F3
holding GLUE Stock Option (Right to Buy) Aug 8, 2023 Common Stock 35.9K $7.78 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs") granted under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement.
F2 25% of this option vested and became exercisable on March 17, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
F3 25% of this option vested and became exercisable on January 1, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
F4 25% of this option shall vest and become exercisable on January 1, 2024, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney